Mitochondrial Biology and Neurological Diseases
- PMID: 26903445
- PMCID: PMC4825945
- DOI: 10.2174/1570159x13666150703154541
Mitochondrial Biology and Neurological Diseases
Abstract
Mitochondria are extremely active organelles that perform a variety of roles in the cell including energy production, regulation of calcium homeostasis, apoptosis, and population maintenance through fission and fusion. Mitochondrial dysfunction in the form of oxidative stress and mutations can contribute to the pathogenesis of various neurodegenerative diseases such as Parkinson's (PD), Alzheimer's (AD), and Huntington's diseases (HD). Abnormalities of Complex I function in the electron transport chain have been implicated in some neurodegenerative diseases, inhibiting ATP production and generating reactive oxygen species that can cause major damage to mitochondria. Mutations in both nuclear and mitochondrial DNA can contribute to neurodegenerative disease, although the pathogenesis of these conditions tends to focus on nuclear mutations. In PD, nuclear genome mutations in the PINK1 and parkin genes have been implicated in neurodegeneration [1], while mutations in APP, PSEN1 and PSEN2 have been implicated in a variety of clinical symptoms of AD [5]. Mutant htt protein is known to cause HD [2]. Much progress has been made to determine some causes of these neurodegenerative diseases, though permanent treatments have yet to be developed. In this review, we discuss the roles of mitochondrial dysfunction in the pathogenesis of these diseases.
Similar articles
-
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.
-
Mitochondrial biogenesis: pharmacological approaches.Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118. Curr Pharm Des. 2014. PMID: 24606795
-
Mitochondrial respiratory chain dysfunction: implications in neurodegeneration.Free Radic Biol Med. 2012 Aug 1;53(3):595-609. doi: 10.1016/j.freeradbiomed.2012.05.009. Epub 2012 May 14. Free Radic Biol Med. 2012. PMID: 22595027 Review.
-
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.Mitochondrion. 2023 Jul;71:83-92. doi: 10.1016/j.mito.2023.05.007. Epub 2023 Jun 1. Mitochondrion. 2023. PMID: 37269968 Review.
-
Mitochondria, oxidative stress and neurodegeneration.J Neurol Sci. 2012 Nov 15;322(1-2):254-62. doi: 10.1016/j.jns.2012.05.030. Epub 2012 Jun 4. J Neurol Sci. 2012. PMID: 22669122 Review.
Cited by
-
Centella asiatica - Phytochemistry and mechanisms of neuroprotection and cognitive enhancement.Phytochem Rev. 2018 Feb;17(1):161-194. doi: 10.1007/s11101-017-9528-y. Epub 2017 Sep 20. Phytochem Rev. 2018. PMID: 31736679 Free PMC article.
-
Antioxidant Efficacy of Hwangryunhaedok-tang through Nrf2 and AMPK Signaling Pathway against Neurological Disorders In Vivo and In Vitro.Int J Mol Sci. 2024 Feb 15;25(4):2313. doi: 10.3390/ijms25042313. Int J Mol Sci. 2024. PMID: 38396988 Free PMC article.
-
ApoE4 (Δ272-299) induces mitochondrial-associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron.Cell Biosci. 2021 Mar 6;11(1):50. doi: 10.1186/s13578-021-00563-y. Cell Biosci. 2021. PMID: 33676568 Free PMC article.
-
Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice.Curr Rheumatol Rep. 2020 Feb 14;22(3):8. doi: 10.1007/s11926-020-0879-9. Curr Rheumatol Rep. 2020. PMID: 32067119 Review.
-
Curcumin pre-treatment may protect against mitochondrial damage in LRRK2-mutant Parkinson's disease and healthy control fibroblasts.Biochem Biophys Rep. 2021 Jun 16;27:101035. doi: 10.1016/j.bbrep.2021.101035. eCollection 2021 Sep. Biochem Biophys Rep. 2021. PMID: 34189277 Free PMC article.
References
-
- Richardson J.R., Caudle W.M., Guillot T.S., Watson J.L., Nakamaru-Ogiso E., Seo B.B., Sherer T.B., Greenamyre J.T., Yagi T., Matsuno-Yagi A., Miller G.W. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol. Sci. 2007;95(1):196–204. doi: 10.1093/toxsci/kfl133. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical